Archive for October 2020
Transamerica was a huge real estate deal. But it’s not the biggest in San Francisco history.
Are you a property geek? You'll love what we've compiled.
BizSpotlight: CREW East Bay
Crew East Bay, the Local Chapter of Crew Network,
Purple Communications to lay off 42 at Rocklin headquarters
The technology company that provides video sign-language relay services has told state employment officials it is laying off 42 positions in Rocklin permanently.
Breast cancer drug developer Olema charts $100M IPO with help from former Genentech players
The San Francisco company, which this summer added a handful of Genentech alumni, including former CEO Ian Clark, started a clinical trial in August for its experimental metastatic breast cancer drug.
The week in bankruptcies: Gregory G. Smith MD PC, Foundation for Pool & Spa Industry Education and 1 more
This week in Sacramento business bankruptcies includes Gregory G. Smith MD PC, Foundation for Pool & Spa Industry Education and more. For the year, Sacramento has recorded 50 business bankruptcy filings.
Arden-Arcade apartments sold for $17.6 million to group expanding locally
With its second purchase this month of a Sacramento region apartment property, 29th Street Capital continues to expand its local footprint.
The Funded: Intel purchases S.F. startup while its chip rivals buy each other
Intel hopes to augment its AI business with a new startup purchase, and the week closes out with almost $200 million in funding raised by 16 startups.
Beauty companies Ipsy and BoxyCharm merge to form mega makeup subscription service
San Mateo-based Ipsy buys a cross-country rival to form what could be a billion-dollar beauty subscription service.
Communications logistics company CTDI to lay off 119 in Lincoln
A year ago, the company had a layoff of 128 people from its location near Lincoln Regional Airport.
Why Samsung Biologics chose the Peninsula for its first major expansion
The South San Francisco center puts the company within a short walk of dozens of biotech companies looking to develop new drugs while controlling their costs by using contractors.